CaroGen Company
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
Estimated Revenue:
Less than $1M
Funding Status:
Seed
Industry:
Viral Vectors
Investors Number:
2
Last Funding Date:
2019-03-27
Founded Date:
2012-01-01
Headquarters:
Hamden, Connecticut, United States
Total Funding:
1550000
Last Funding Type:
Grant
Employee Number:
1-10